Experience

CoLAB AccelBio

• Portugal
• Biotechnology Research
• 1 - 100 Employee

• • Jan 2023 - Present

• • May 2022 - Dec 2022



Instituto de Medicina Molecular

• Portugal
• Research
• 300 - 400 Employee

• • Aug 2018 - Dec 2022

  • Screening, evaluation and marketing of new Technologies derived from R&D projects in thetherapeutic areas of Oncology, Neurology, Immunology and Infection; • Promotion of research collaborations with pharmaceutical and biotechnology companies;• Promotion of investigator-initiated studies;• Intellectual property management;• Negotiation of research and licensing agreements;• Start-up creation – support on business plan preparation and definition of investment strategy.

• • Dec 2017 - Jul 2018

  • Assistance in grants preparation - support on budget planning, ethics compliance, draftinginstitutional texts or parts of proposal, proposal review and proof-reading;• Liaison with national and international funding, policy and executive agencies;• Negotiation of successfully funded projects.

• • Apr 2014 - Nov 2017

  "Characterization of enveloped viruses inhibition by 25-hydroxycholesterol at the membrane level" • Determination of the role of 25-hydroxycholesterol as a new viral fusion inhibitor• Clarification of the interaction between antiviral peptides with a 25-hydroxycholesterol moeity and membrane model systems/human blood cellsExperience on ATR-FTIR spectroscopy, UV measurements, fluorescence assays, dynamic light scattering and confocal microscopy.



Columbia University Irving Medical Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Visiting Researcher

  • Mar 2016 - Aug 2016



Faculdade de Engenharia da Universidade do Porto

• Portugal
• Higher Education
• 700 & Above Employee

• Research Fellow

  • Mar 2012 - Mar 2014

  "Antibody-directed liposomes for Alzheimer`s disease" "Antibody-directed liposomes for Alzheimer`s disease"